Cleveland Clinic's Marisa McGinley, DO; Robert Bermel, MD; and Rebecca Cebull, CNP, open the series by defining what precision medicine means in MS and how far the field has moved past a one-size-fits-all approach to treatment.
Precision Medicine in Multiple Sclerosis: Advances & Unanswered Questions
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease
2
CSF Biomarkers Identify Shared LRRK2 Pathway Activation in Sporadic and LRRK2-Associated Parkinson Disease
3
Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches
4
Phase 4 THRIVE Data Highlights Eptinezumab’s Impact on Migraine After Prior CGRP Failure
5